Q How do current trends influence custom or OEM pharmaceutical intermediate sourcing
Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner
Semaglutide, originally developed for type 2 diabetes management, has demonstrated significant weight loss results in clinical trials, with patients losing up to 15% of body weight over 68 weeks
When Things Get More Serious The bigger concerns are rare, but they're worth knowing about
This connects you with the guidance you need right away
CMS has also shared a pharmacy fact sheet ( that provides an overview of the Medicare GLP-1 Bridge Program and outlines the pharmacy workflow for determining beneficiary eligibility, submitting claims, supporting prior authorization, and dispensing covered GLP-1 medications